Original news and analysis on international IP policy
Public health stakeholders – and just about everyone else – may take notice of a meeting planned for May in the Netherlands, as it could offer the beginning of a new approach to pharmaceutical costs. High drug prices have become a ‘kitchen table’ issue in countries of all economic sizes recently, and the World Health Organization is teaming up with the Dutch government to address it in a new and practical way.
Financing for research and development into so-called neglected diseases – those predominantly affecting lower-income populations – rose recently mainly due to the Ebola outbreak, and private sector contributions represent a bigger share, according to the latest available data from a Gates Foundation-supported database.
The Global Fund to Fight AIDS, Tuberculosis and Malaria is deliberating on how to start over on its search for a new executive director after questions arose near the end of the process.
The lack of access to medical products has spread from being a developing country problem to a global one as prices are now too high even for developed country patients and health systems for some medicines. An event at the Graduate Institute Global Public Health Centre yesterday was an opportunity to explore these issues.
In the face of the lack of attractiveness of investing in research for new antibiotics for the pharmaceutical industry, and the general lack of funding for research and development for novel antibiotics, a new report commissioned by the German Federal Ministry of Health calls for countries to take action. In particular, the report proposes a global union for research and development, a global research fund, and a global launch reward. And access and pricing are key components of the strategy, it says.
Multilateral institutions have received a lift with the realization of the World Trade Organization’s Trade Facilitation Agreement that is expected to provide a boost to sluggish international commerce by cutting out clogging regulations. Image Credits: Peter Kenny
With the start of a new era in providing high-quality global news and information, Intellectual Property Watch is proud to announce the addition of three distinguished and eminent experts in their fields as new members of the IP-Watch Board of Directors.
NAIROBI, Kenya -- In a move meant to streamline the collection of music royalties in Kenya, the government regulator declined to renew a 2017 licence for a leading collective organisation over unmet standards.
NEW YORK -- At a recent biotechnology investors event in the United States, the prospect of repeal or redesign of the Affordable Care Act, the president’s recent remarks on the prospect of Medicare negotiating prices directly with pharmaceutical corporations, and the public debate surrounding high priced medicines, meant few panels were immune from questions of affordability, access and payment.
MUNICH -- For the Pirate Party gathered at the Pirate Security Conference (PirateSecon) in Munich this is bad news. On the eve of the PirateSecon, held alongside the big Munich Security Conference, the city council of Munich decided to reverse the once-celebrated migration to LiMux, its much reported about Linux platform. For the German Pirate Party, the dismantling of “LiMux” is a step in the wrong direction. At the third edition of the Pirate Security Conference Pirate Party members from Luxembourg, Iceland, Switzerland and the Czech Republic discussed how to take back data and even algorithms – and how to win elections.
There are a vast amount of ways in which you can structure an intellectual property collaboration between a university and business. This article looks to provide guidance and points for consideration by both sides.
Once considered a breakthrough in negotiations to address problems of making cutting-edge medical products and research available to poor countries, the decade-old World Health Organization Global Strategy and Plan of Action on Public Health, Innovation and Intellectual Property (GSPOA) is now undergoing review, with the WHO Executive Board calling for a report on the initiative and plans for its future next year.